Corvus Pharmaceuticals, Inc.'s Chief Financial Officer was just granted 160,000 options

Leiv Lea, Corvus Pharmaceuticals, Inc.'s Chief Financial Officer, just received 160,000 options from the company. The strike price of the options received was $3.54, and these expire on December 12, 2029. Lea now owns at least 160,000 options on the company.

Some additional info was provided as follows:


The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020

Auto Refresh

Feedback